United States · FDA National Drug Code directory
Fluorodopa F18
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13267-346_f8d69c66-d9aa-4bb8-bb56-5bebeef87af5
- Product NDC
- 13267-346
- Form
- INJECTION
- Composition / generic term
- Fluorodopa F18
- Labeler
- THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
- Marketing category
- NDA
- Marketing start / end (source format)
- 20191010
- Source listing expiry
- 20261231
Source-listed ingredients
- FLUORODOPA F-18 — 40 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 VIAL, GLASS (13267-346-57) · 13267-346-57
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →